Mildred K. Buening

1.6k total citations
26 papers, 1.3k citations indexed

About

Mildred K. Buening is a scholar working on Pharmacology, Molecular Biology and Biochemistry. According to data from OpenAlex, Mildred K. Buening has authored 26 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pharmacology, 8 papers in Molecular Biology and 8 papers in Biochemistry. Recurrent topics in Mildred K. Buening's work include Eicosanoids and Hypertension Pharmacology (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Mildred K. Buening is often cited by papers focused on Eicosanoids and Hypertension Pharmacology (7 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Carcinogens and Genotoxicity Assessment (3 papers). Mildred K. Buening collaborates with scholars based in United States and Switzerland. Mildred K. Buening's co-authors include Allan H. Conney, Joseph G. Fortner, Wayne Levin, Alexander W. Wood, Richard L. Chang, Haruhiko Yagi, M R Franklin, Dhiren R. Thakker, D. M. JERINA and Mou‐Tuan Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Mildred K. Buening

26 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mildred K. Buening United States	17	576	490	329	205	162	26	1.3k
Gerald M. Holder Australia	16	466 0.8×	422 0.9×	353 1.1×	136 0.7×	195 1.2×	67	1.3k
D. V. Parke United Kingdom	23	435 0.8×	489 1.0×	284 0.9×	141 0.7×	135 0.8×	50	1.5k
Kenneth C. Leibman United States	26	645 1.1×	753 1.5×	326 1.0×	226 1.1×	160 1.0×	54	1.8k
Joan Booth United Kingdom	19	718 1.2×	363 0.7×	240 0.7×	119 0.6×	226 1.4×	27	1.4k
Kostas P. Vatsis United States	17	777 1.3×	504 1.0×	356 1.1×	244 1.2×	74 0.5×	29	1.5k
A. H. Conney United States	31	605 1.1×	940 1.9×	297 0.9×	277 1.4×	148 0.9×	56	2.1k
Jan J.P. Bogaards Netherlands	23	936 1.6×	557 1.1×	208 0.6×	242 1.2×	117 0.7×	39	1.8k
Preston H. Grantham United States	19	423 0.7×	288 0.6×	293 0.9×	174 0.8×	101 0.6×	53	1.0k
H. Uehleke Germany	21	453 0.8×	680 1.4×	258 0.8×	210 1.0×	87 0.5×	101	1.5k
Guengerich Fp United States	13	436 0.8×	558 1.1×	335 1.0×	207 1.0×	62 0.4×	24	1.1k

Countries citing papers authored by Mildred K. Buening

Since Specialization

Citations

This map shows the geographic impact of Mildred K. Buening's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mildred K. Buening with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mildred K. Buening more than expected).

Fields of papers citing papers by Mildred K. Buening

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mildred K. Buening. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mildred K. Buening. The network helps show where Mildred K. Buening may publish in the future.

Co-authorship network of co-authors of Mildred K. Buening

This figure shows the co-authorship network connecting the top 25 collaborators of Mildred K. Buening. A scholar is included among the top collaborators of Mildred K. Buening based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mildred K. Buening. Mildred K. Buening is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Byrd, Richard A., Christian L. Gries, & Mildred K. Buening. (1994). Developmental Toxicology Studies of Vancomycin Hydrochloride Administered Intravenously to Rats and Rabbits. Toxicological Sciences. 23(4). 590–597. 2 indexed citations

Williams, Patricia D., et al.. (1991). Cardiovascular and autonomic pharmacology of the macrolide antibiotic LY281389 in anesthetized beagles and in isolated smooth and cardiac muscles. Antimicrobial Agents and Chemotherapy. 35(7). 1365–1369. 6 indexed citations

Williams, Patricia D., Mildred K. Buening, Christian L. Gries, et al.. (1990). Comparative toxicity of oral cephalosporin antibiotics in the rabbit and in a rabbit kidney cell line (LLC-RK1). Toxicology in Vitro. 4(3). 207–210. 4 indexed citations

Buening, Mildred K., Wayne Levin, Alexander W. Wood, et al.. (1983). Fluorine Substitution as a Probe for the Role of the 6-Position of Benzo[<italic>a</italic>]pyrene in Carcinogenesis<xref ref-type="fn" rid="FN2">2</xref><xref ref-type="fn" rid="FN3">3</xref>. JNCI Journal of the National Cancer Institute. 71(2). 309–15. 15 indexed citations

Wold, John S., et al.. (1983). LATAMOXEF-ASSOCIATED HYPOPROTHROMBINAEMIA. The Lancet. 322(8346). 408–408. 16 indexed citations

Buening, Mildred K. & John S. Wold. (1982). Ethanol-Moxalactam Interactions in Vivo. Clinical Infectious Diseases. 4(Supplement_3). S555–S563. 24 indexed citations

Levin, Wayne, Mildred K. Buening, Alexander W. Wood, et al.. (1980). An enantiomeric interaction in the metabolism and tumorigenicity of (+)- and (-)-benzo[a]pyrene 7,8-oxide.. Journal of Biological Chemistry. 255(19). 9067–9074. 61 indexed citations

Buening, Mildred K., Wayne Levin, Alexander W. Wood, et al.. (1980). Tumorigenic activity of benzo(e)pyrene derivatives on mouse skin and in newborn mice.. PubMed. 40(2). 203–6. 14 indexed citations

Wislocki, Peter G., Mildred K. Buening, Wayne Levin, et al.. (1979). Tumorigenicity of the Diastereomeric Benz[<italic>a</italic>]anthracene 3,4-Diol-1,2-epoxides and the (+)- and (−)-Enantiomers of Benz[<italic>a</italic>]anthracene 3,4-Dihydrodiol in Newborn Mice. JNCI Journal of the National Cancer Institute. 63(1). 201–4. 25 indexed citations

10.

Buening, Mildred K., Wayne Levin, Alexander W. Wood, et al.. (1979). Tumorigenicity of the dihydrodiols of dibenzo(a,h)anthracene on mouse skin and in newborn mice.. PubMed. 39(4). 1310–4. 21 indexed citations

11.

Buening, Mildred K., Wayne Levin, Jean M. Karle, et al.. (1979). Tumorigenicity of bay-region epoxides and other derivatives of chrysene and phenanthrene in newborn mice.. PubMed. 39(12). 5063–8. 32 indexed citations

12.

Thakker, Dhiren R., Haruhiko Yagi, Roland E. Lehr, et al.. (1978). Metabolism of trans-9,10-Dihydroxy-9,10-dihydrobenzo[a]pyrene Occurs Primarily by Arylhydroxylation Rather than Formation of a Diol Epoxide. Molecular Pharmacology. 14(3). 502–513. 37 indexed citations

13.

Buening, Mildred K., Peter G. Wislocki, Wayne Levin, et al.. (1978). Tumorigenicity of the optical enantiomers of the diastereomeric benzo[a]pyrene 7,8-diol-9,10-epoxides in newborn mice: exceptional activity of (+)-7beta,8alpha-dihydroxy-9alpha,10alpha-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene.. Proceedings of the National Academy of Sciences. 75(11). 5358–5361. 334 indexed citations

14.

Buening, Mildred K., Joseph G. Fortner, Attallah Kappas, & Allan H. Conney. (1978). 7,8-Benzoflavone stimulates the metabolic activation of aflatoxin B1 to mutagens by human liver. Biochemical and Biophysical Research Communications. 82(1). 348–355. 54 indexed citations

15.

Kapitulnik, Jaime, P. J. Poppers, Mildred K. Buening, Joseph G. Fortner, & Allan H. Conney. (1977). Activation of monooxygenases in human liver by 7,8‐benzoflavone. Clinical Pharmacology & Therapeutics. 22(4). 475–484. 53 indexed citations

16.

Buening, Mildred K. & M R Franklin. (1976). The formation of cytochrome P-450-metabolic intermediate complexes in microsomal fractions from extrahepatic tissues of the rabbit.. Drug Metabolism and Disposition. 4(6). 556–561. 11 indexed citations

17.

Buening, Mildred K., et al.. (1974). THE FORMATION OF COMPLEXES ABSORBING AT 455 NM FROM CYTOCHROME P-450 AND METABOLITES OF COMPOUNDS RELATED TO SKF 525-A. Drug Metabolism and Disposition. 2(4). 386–390. 7 indexed citations

18.

Buening, Mildred K. & Michael R. Franklin. (1974). The formation of complexes absorbing at 455 nm from cytochrome P-450 and metabloites of compounds related to SKF 525-A.. PubMed. 2(4). 386–90. 33 indexed citations

19.

Buening, Mildred K. & Michael R. Franklin. (1974). Limitations in the Use of the 340 nm Absorbance Maximum of Reduced Nicotinamide Adenine Dinucleotide Phosphate for the Determination of Oxidation Rates and Stoichiometry during Rat Hepatic Microsomal Metabolism. Molecular Pharmacology. 10(6). 999–1003. 14 indexed citations

20.

Buening, Mildred K. & James W. Gibb. (1974). Influence of methamphetamine and neuroleptic drugs on tyrosine hydroxylase activity. European Journal of Pharmacology. 26(1). 30–34. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact